Reporte de caso
Hiponatremia luego de uso de cisplatino: a propósito de un caso
Hyponatraemia after cisplatin use: a case report
Alan Ovallea,b,
, Diego Gonzáleza,c, Carlos Bonillaa,c, Ricardo Brugésa,c, Catalina Rúa Marínd
Autor para correspondencia
a Departamento de Oncología Clínica, Instituto Nacional de Cancerología, Bogotá, D. C., Colombia
b Facultad de Medicina, Medicina Interna, Fundación Universitaria Juan N. Corpas, Bogotá, D. C., Colombia
c Facultad de Medicina, Oncología Clínica, Universidad del Bosque, Bogotá, D. C., Colombia
d Facultad de Medicina, Endocrinología, Universidad de Antioquia, Medellín, Colombia
Leído
7663
Vecesse ha leído el artículo
1057
Total PDF
6606
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 15 | 5 | 20 |
| 2025 11 | 93 | 24 | 117 |
| 2025 10 | 67 | 9 | 76 |
| 2025 9 | 59 | 14 | 73 |
| 2025 8 | 58 | 18 | 76 |
| 2025 7 | 104 | 6 | 110 |
| 2025 6 | 60 | 7 | 67 |
| 2025 5 | 89 | 7 | 96 |
| 2025 4 | 80 | 4 | 84 |
| 2025 3 | 117 | 11 | 128 |
| 2025 2 | 108 | 11 | 119 |
| 2025 1 | 55 | 1 | 56 |
| 2024 12 | 59 | 5 | 64 |
| 2024 11 | 71 | 4 | 75 |
| 2024 10 | 91 | 10 | 101 |
| 2024 9 | 56 | 14 | 70 |
| 2024 8 | 61 | 10 | 71 |
| 2024 7 | 80 | 6 | 86 |
| 2024 6 | 72 | 9 | 81 |
| 2024 5 | 70 | 6 | 76 |
| 2024 4 | 49 | 3 | 52 |
| 2024 3 | 97 | 9 | 106 |
| 2024 2 | 63 | 9 | 72 |
| 2024 1 | 70 | 4 | 74 |
| 2023 12 | 62 | 9 | 71 |
| 2023 11 | 72 | 5 | 77 |
| 2023 10 | 72 | 13 | 85 |
| 2023 9 | 68 | 12 | 80 |
| 2023 8 | 65 | 8 | 73 |
| 2023 7 | 104 | 9 | 113 |
| 2023 6 | 45 | 8 | 53 |
| 2023 5 | 88 | 10 | 98 |
| 2023 4 | 71 | 7 | 78 |
| 2023 3 | 99 | 8 | 107 |
| 2023 2 | 72 | 9 | 81 |
| 2022 1 | 74 | 3 | 77 |
| 2022 12 | 52 | 12 | 64 |
| 2022 11 | 64 | 9 | 73 |
| 2022 10 | 62 | 10 | 72 |
| 2022 9 | 44 | 15 | 59 |
| 2022 8 | 46 | 10 | 56 |
| 2022 7 | 43 | 17 | 60 |
| 2022 6 | 36 | 13 | 49 |
| 2022 5 | 56 | 30 | 86 |
| 2022 4 | 40 | 20 | 60 |
| 2022 3 | 55 | 13 | 68 |
| 2022 2 | 62 | 13 | 75 |
| 2021 1 | 82 | 12 | 94 |
| 2021 12 | 66 | 6 | 72 |
| 2021 11 | 65 | 13 | 78 |
| 2021 10 | 88 | 17 | 105 |
| 2021 9 | 85 | 18 | 103 |
| 2021 8 | 69 | 6 | 75 |
| 2021 7 | 59 | 12 | 71 |
| 2021 6 | 66 | 7 | 73 |
| 2021 5 | 89 | 5 | 94 |
| 2021 4 | 159 | 27 | 186 |
| 2021 3 | 92 | 21 | 113 |
| 2021 2 | 65 | 13 | 78 |
| 2020 1 | 49 | 10 | 59 |
| 2020 12 | 41 | 7 | 48 |
| 2020 11 | 48 | 11 | 59 |
| 2020 10 | 46 | 4 | 50 |
| 2020 9 | 49 | 7 | 56 |
| 2020 8 | 63 | 11 | 74 |
| 2020 7 | 48 | 15 | 63 |
| 2020 6 | 42 | 14 | 56 |
| 2020 5 | 43 | 4 | 47 |
| 2020 4 | 39 | 5 | 44 |
| 2020 3 | 47 | 3 | 50 |
| 2020 2 | 24 | 4 | 28 |
| 2020 1 | 43 | 13 | 56 |
| 2019 12 | 58 | 11 | 69 |
| 2019 11 | 30 | 9 | 39 |
| 2019 10 | 32 | 16 | 48 |
| 2019 9 | 30 | 9 | 39 |
| 2019 8 | 27 | 5 | 32 |
| 2019 7 | 36 | 4 | 40 |
| 2019 6 | 119 | 17 | 136 |
| 2019 5 | 324 | 38 | 362 |
| 2019 4 | 146 | 10 | 156 |
| 2019 3 | 14 | 7 | 21 |
| 2019 2 | 21 | 5 | 26 |
| 2019 1 | 34 | 11 | 45 |
| 2018 12 | 35 | 6 | 41 |
| 2018 11 | 37 | 14 | 51 |
| 2018 10 | 68 | 2 | 70 |
| 2018 9 | 99 | 9 | 108 |
| 2018 8 | 44 | 3 | 47 |
| 2018 7 | 35 | 2 | 37 |
| 2018 6 | 37 | 7 | 44 |
| 2018 5 | 26 | 4 | 30 |
| 2018 4 | 27 | 1 | 28 |
| 2018 3 | 20 | 3 | 23 |
| 2018 2 | 18 | 3 | 21 |
| 2018 1 | 12 | 2 | 14 |
| 2017 12 | 27 | 0 | 27 |
| 2017 11 | 14 | 3 | 17 |
| 2017 10 | 23 | 6 | 29 |
| 2017 9 | 25 | 1 | 26 |
| 2017 8 | 22 | 4 | 26 |
| 2017 7 | 25 | 1 | 26 |
| 2017 6 | 19 | 1 | 20 |
| 2017 5 | 30 | 3 | 33 |
| 2017 4 | 41 | 4 | 45 |
| 2017 3 | 38 | 5 | 43 |
| 2017 2 | 47 | 11 | 58 |
| 2016 1 | 29 | 5 | 34 |
| 2016 12 | 36 | 14 | 50 |
| 2016 11 | 40 | 26 | 66 |
| 2016 10 | 57 | 22 | 79 |
| 2016 9 | 26 | 8 | 34 |
| 2016 8 | 10 | 4 | 14 |
| 2016 7 | 5 | 7 | 12 |
Mostrar todo
